2022-10-04T06:51:40-05:00 2022-03-31 111986323 MARCUM LLP 1899 L STREET NW SUITE 850 WASHINGTON DC 20036 990 2021-04-01 760514428 MELANOMA RESEARCH FOUNDATION MELA 8006731290 1420 K STREET NW 7TH FLOOR WASHINGTON DC 20005 KYLEIGH LIPIRA CEO 8006731290 2022-10-03 1 KYLEIGH LIPIRA 999009999 FRANK H SMITH P00639053 2022274000 2022-10-02 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z KYLEIGH LIPIRA 1420 K STREET NW 7TH FLOOR WASHINGTON DC 20005 7235631 0 X WWW.MELANOMA.ORG X 1996 TX TO ERADICATE MELANOMA BY ACCELERATING MEDICAL RESEARCH WHILE EDUCATING TO AND ADVOCATING FOR THE MELANOMA COMMUNITY. 11 10 23 475 0 0 5117283 6964814 0 0 5925 21447 5037 -68203 5128245 6918058 1273000 1151805 0 0 1500797 1477972 0 0 486091 2034654 2945533 4808451 5575310 319794 1342748 4048990 5064088 2234814 1895502 1814176 3168586 THE MRF IS THE LARGEST INDEPENDENT ORGANIZATION DEVOTED TO MELANOMA. ITS MISSION IS TO ERADICATE MELANOMA BY ACCELERATING MEDICAL RESEARCH WHILE EDUCATING TO AND ADVOCATING FOR THE MELANOMA COMMUNITY. 0 0 1944168 1151805 THE MRF IS COMMITTED TO ADVANCING A BROAD SCIENTIFIC AGENDA ACROSS THE DISCIPLINES OF PREVENTION, DIAGNOSIS AND TREATMENT. ALTHOUGH THE MRF HAS ACHIEVED A NUMBER OF IMPORTANT SCIENTIFIC MILESTONES, MUCH MORE WORK REMAINS TO BE DONE. TO THIS END, THE MRF FUNDS A SPECTRUM OF RESEARCH GRANTS, SCIENTIFIC INITIATIVES, AND PROGRAMS FOR CUTANEOUS MELANOMA AND RARER MELANOMA SUBTYPES (E.G. OCULAR, PEDIATRIC, ACRAL AND MUCOSAL MELANOMA). ITS RESEARCH GRANT PROGRAM IS A COMPETITIVE, PEER-REVIEWED RESEARCH GRANT PROGRAM FOR INVESTIGATOR-INITIATED RESEARCH HAS BEEN IN EXISTENCE SINCE 1998. MRF-SUPPORTED RESEARCH IS OPEN TO MEDICAL STUDENTS THROUGH SENIOR INVESTIGATIVE TEAMS AND ENCOMPASS. 1390242 THE MRF HAS A ROBUST EDUCATION PROGRAM AIMED AT EDUCATING PATIENTS AND PHYSICIANS ABOUT THE PREVENTION, DIAGNOSIS AND TREATMENT OF MELANOMA, AS WELL AS INCREASING OVERALL AWARENESS OF THE DISEASE. IN ADDITION, THE MRF MAINTAINS A LARGE PORTFOLIO OF FREE EDUCATIONAL MATERIALS THAT CAN BE USED AT FUNDRAISERS, DOCTORS' OFFICES, SCHOOLS AND HEALTH FAIRS.PART OF THE MRF'S EDUCATIONAL OFFERINGS ALSO INCLUDE PATIENT-FOCUSED EDUCATIONAL SYMPOSIA THROUGHOUT THE U.S., IMPACTING NEARLY 1,400 PEOPLE TOUCHED BY MELANOMA. THESE SYMPOSIA PROVIDE MELANOMA PATIENTS AND THE PEOPLE WHO SUPPORT THEM THE OPPORTUNITY TO LEARN FROM LEADING MELANOMA EXPERTS ON THE MOST CURRENT PREVENTION, DIAGNOSIS, TREATMENT AND RESEARCH INFORMATION. 904988 THE MRF'S ADVOCACY PROGRAM IS A PLATFORM FOR THOSE AFFECTED BY MELANOMA TO SHARE THEIR VOICE AND TRANSFORM MELANOMA CARE. PATIENTS, CAREGIVERS, SURVIVORS, HEALTHCARE PROFESSIONALS AND PARTNERS ALL PLAY A CRITICAL ROLE IN THE ADVANCEMENT OF BETTER OUTCOMES FOR THE OVER ONE MILLION AMERICANS LIVING WITH MELANOMA AND THEIR LOVED ONES. 4239398 1 1 0 1 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 1 1 1 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 1 37 0 1 23 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 11 10 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY MA MD ME MI MN MS NC ND NH NJ NM NY OH OK OR PA RI UT VA WA WI WV TN SC X KYLEIGH LIPIRA 8006731290 1420 K STREET NW 7TH FLOOR WASHINGTON DC 20005 KYLEIGH LIPIRA CEO 40.00 X 261731 0 9016 SUSAN VOGEL CHIEF DEVELOPMENT OFFICER - UNTIL 02/2022 40.00 X 150000 0 19606 DOUGLAS BRODMAN CHAIR 2.00 X X 0 0 0 ALISON MARTIN VICE CHAIR - AS OF 12/2021 2.00 X X 0 0 0 CHERYL STRATOS SECRETARY 2.00 X X 0 0 0 JILL WROBEL TREASURER - AS OF 12/2021 2.00 X X 0 0 0 STAN ADLER BOARD MEMBER 1.00 X 0 0 0 MICHAEL B ATKINS MD SAC CO-CHAIR 1.00 X 0 0 0 ELISE BARISH BOARD MEMBER 1.00 X 0 0 0 LAURA FERRIS BOARD MEMBER 1.00 X 0 0 0 ANTHONY T HENDRICKSON BOARD MEMBER - UNTIL 12/2021 1.00 X 0 0 0 GLENN MERLINO SAC CO-CHAIR 1.00 X 0 0 0 WILLIAM G REILLY BOARD MEMBER - UNTIL 12/2021 1.00 X 0 0 0 STEVE SILVERSTEIN BOARD MEMBER - UNTIL 12/2021 2.00 X X 0 0 0 MARK WEINZIERL BOARD MEMBER 1.00 X 0 0 0 TOM WESTDYK BOARD MEMBER 1.00 X 0 0 0 411731 0 28622 2 0 1 0 CLIFTONLARSONALLEN LLP PO BOX 930256 ATLANTA GA 322930256 OUTSOURCED ACCOUNTING SERVICES 282590 BLACKBAUD PO BOX 829709 PHILADELPHIA PA 191829709 DONOR DATABASE & ACCOUNTING SUPPORT 182338 SARA SELIG 24 HALIFAX APARTMENT 1 JAMAICA PLAIN MD 02130 CURE OM DIRECTORSHIP AND REGISTRY 116840 THE EMMES COMPANY LLC 401 N WASHINGTON STREET SUITE 700 ROCKVILLE MD 20850 CLINICAL RESEARCH SERVICES 103195 4 656436 268700 6039678 29282 6964814 10450 10450 33917 22920 10997 10997 10997 226450 656436 294653 -68203 -68203 6918058 0 0 -46756 X 1118805 1118805 33000 33000 302654 78691 133168 90795 1000894 876044 79250 45600 14879 14454 339 86 74394 55491 11533 7370 85151 62644 13712 8795 290501 21950 268551 78039 78039 778759 633722 40472 104565 100240 70483 21049 8708 336345 236501 70626 29218 384264 246906 110346 27012 208826 134179 59967 14680 137485 109917 12444 15124 501656 378530 36 123090 65280 45901 13708 5671 18696 12013 5369 1314 REGISTRATION FEES 20575 14467 4320 1788 RECOGNITION/AWARDS 13657 9603 2868 1186 STAFF DEVELOPMENT 7580 5506 1301 773 MEMBERSHIP DUES 3630 2552 762 316 5575310 4239398 849821 486091 2471261 3163821 41062 0 636387 828358 343491 282600 718706 493575 214835 225131 341954 564178 4048990 5064088 271165 342508 1106202 964107 515505 249487 341942 339400 2234814 1895502 X -1126822 312979 2940998 2855607 1814176 3168586 4048990 5064088 X 1342748 6688 4974 X 0 1 X 1 0 X 5873258 5290886 5777261 5117283 6964814 29023502 5873258 5290886 5777261 5117283 6964814 29023502 4533753 24489749 56 123 6878 5925 10450 23432 2552 1789 913 5037 10291 29057225 930963 0.84280 0.89070 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER - 2017 AMOUNT: $ 2,552. 2018 AMOUNT: $ 1,789. 2019 AMOUNT: $ 913. 2020 AMOUNT: $ 5,037. 2021 AMOUNT: $ 0. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 0 0 0 1 78039 78039 0 PART II-B, LINE 1: A LOBBY FIRM IS RETAINED TO ASSIST WITH DEVELOPING, COORDINATING AND IMPLEMENTING AN ALL-ENCOMPASSING ADVOCACY PROGRAM WHICH INCLUDES BUT IS NOT LIMITED TO FEDERAL FUNDING FOR MELANOMA RESEARCH, ISSUES RELATED TO ADOLESCENTS AND YOUNG ADULTS, PEDIATRIC PATIENTS, RARE MELANOMA SUBTYPES, ACCESS TO CARE, PREVENTION AND SURVIVORSHIP. 696488 -3941 692547 1.00000 0 0 170608 40375 130233 353946 339691 14255 194152 113509 80643 225131 DEFERRED RENT AND LEASE INCENTIVES 339400 339400 X 8106424 6688 887025 294653 1188366 6918058 0 6918058 6752014 887025 294653 1181678 5570336 4974 4974 5575310 PART V, LINE 4: MRF ENDOWMENT ACCOUNT EXPENDITURES WILL COINCIDE WITH THE SAME MISSION STATEMENTS AS THE ORGANIZATION. THE CORPUS OF THE ENDOWMENT FUND, COMPRISED OF THE ORIGINAL GIFT(S) AND ANY SUBSEQUENT GIFTS TO THE FUND, IS TO BE HELD IN PERPETUITY AND MAINTAINED AT THE LEVEL OF THE GIFTS MADE TO THE FUND. PART X, LINE 2: THE FOUNDATION PERFORMED AN EVALUATION OF UNCERTAINTY IN INCOME TAXES FOR THE YEAR ENDED MARCH 31, 2022, AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. PART XI, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSE 294,653. PART XII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSE 294,653. PART XII, LINE 4B - OTHER ADJUSTMENTS: REFUND OF GRANT 4,974. GALAS 882886 656436 226450 26266 140113 7728 120546 882886 656436 226450 26266 140113 7728 120546 294653 -68203 1 THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER PO BOX 4266 HOUSTON TX 77210 746001118 501(C)(3) 0 400000 TO SUPPORT MELANOMA CANCER RESEARCH THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 630 WEST 168TH STREET BOX 49 NEW YORK NY 10032 135598093 501(C)(3) 0 150000 TO SUPPORT MELANOMA CANCER RESEARCH CITY OF HOPE 1500 EAST DUARTE ROAD DUARTE CA 91010 953435919 501(C)(3) 0 100000 TO SUPPORT MELANOMA CANCER RESEARCH PRESIDENT AND FELLOWS OF HARVARD COLLEGE 1033 MASSACHUSETTS AVENUE 5TH FLOOR CAMBRIDGE MA 02138 042103580 501(C)(3) 0 100000 TO SUPPORT MELANOMA CANCER RESEARCH ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 1 GUSTAVE L LEVY PLACE NEW YORK NY 10029 136171197 501(C)(3) 0 100000 TO SUPPORT MELANOMA CANCER RESEARCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 490 ILLINOIS STREET 4TH FLOOR SAN FRANCISCO CA 94143 946036493 501(C)(3) 0 100000 TO SUPPORT MELANOMA CANCER RESEARCH CHILDREN'S HOSPITAL OF PITTSBURGH FOUNDATION 4401 PENN AVENUE PITTSBURGH PA 15224 251865744 501(C)(3) 0 99916 TO SUPPORT MELANOMA CANCER RESEARCH CONQUER CANCER FOUNDATION 2318 MILL ROAD SUITE 800 ALEXANDRIA VA 22314 311667995 501(C)(3) 0 36000 TO SUPPORT MELANOMA CANCER RESEARCH VANDERBILT UNIVERSITY MEDICAL CENTER PO BOX 121236 DALLAS TX 75312 352528741 501(C)(3) 0 30000 TO SUPPORT MELANOMA CANCER RESEARCH 9 0 STUDENT MEDICAL AWARDS 11 33000 PART I, LINE 2: THE MRF'S SCIENTIFIC LEADERSHIP IS COMPRISED OF MULTIDISCIPLINARY EXPERTS IN BASIC AND TRANSLATIONAL RESEARCH, DERMATOLOGY, EPIDEMIOLOGY, GENOMICS, PATHOLOGY, SURGERY AND MEDICAL ONCOLOGY. MEMBERS OF ALL OUR ADVISORY/ STEERING COMMITTEES ARE VOLUNTEERS THAT ASSIST IN PROVIDING THE SCIENTIFIC DIRECTION OF THE MRF. X X 0 0 0 0 0 0 0 0 0 KYLEIGH LIPIRA CEO 261731 0 0 0 0 0 7417 0 1599 0 270747 0 0 0 SUSAN VOGEL CHIEF DEVELOPMENT OFFICER - UNTIL 02/2022 150000 0 0 0 0 0 4249 0 15357 0 169606 0 0 0 STAN ADLER ASSOCIATES STAN ADLER, BOARD MEMBER, IS ALSO THE CHAIR AND FOUNDER OF THE ASSOCIATES 79642 MRF PAID A RETAINER FEE TO THE ASSOCIATES FOR GRAPHIC DESIGN AND MARKETING SERVICES. 0 X 6 29282 FMV 0 1 0 PART I, COLUMN (B): THIS COLUMN REPRESENTS THE NUMBER OF ACTUAL CONTRIBUTIONS, NOT THE NUMBER OF ITEMS CONTRIBUTED. FORM 990, PART VI, SECTION B, LINE 11B THE OUTSOURCED ACCOUNTING FIRM AND THE CHIEF EXECUTIVE OFFICER REVIEW THE FEDERAL FORM 990 PREPARED BY AN INDEPENDENT ACCOUNTING FIRM. UPON SUBMISSION OF THE FINAL DRAFT, THE FORM 990 IS DISTRIBUTED TO THE BOARD OF DIRECTORS AND THE FINANCE COMMITTEE FOR THEIR REVIEW PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS DISTRIBUTED ANNUALLY TO ALL MEMBERS OF THE BOARD OF DIRECTORS, KEY PERSONNEL, AND COMMITTEE MEMBERS. EACH RECIPIENT OF THE POLICY RETURNS A SIGNED AND DATED RESPONSE FORM INDICATING THEY REVIEWED THE POLICY WHILE NOTING IF ANY CONFLICTS EXIST. FOLLOWING THE FULL DISCLOSURE OF A POSSIBLE CONFLICT OF INTEREST DURING THE YEAR, THE BOARD OF DIRECTORS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS AND THE BOARD MEMBER WITH THE POSSIBLE CONFLICT WILL RECUSE HIMSELF OR HERSELF FROM THE DISCUSSION AND VOTE. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER IS DETERMINED IN THE EXECUTIVE SESSION OF A BOARD OF DIRECTORS MEETING AND IS BASED UPON COMPARABLE SALARY DATA. THE BOARD OF DIRECTORS CONVENES AN AD HOC COMPENSATION COMMITTEE THAT CONTRACTED WITH AN OUTSIDE EXPERT IN SALARY EVALUATION. APPROPRIATE ADJUSTMENTS ARE MADE TO ENSURE THAT MRF SALARIES ARE IN KEEPING WITH BEST PRACTICES. THE LAST COMPENSATION REVIEW FOR THE EXECUTIVE DIRECTOR WAS CONDUCTED IN 2021. FORM 990, PART VI, SECTION C, LINE 19 MRF'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 542,597. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 92,520. TOTAL EXPENSES 635,117. RECRUITING: PROGRAM SERVICE EXPENSES 75,285. MANAGEMENT AND GENERAL EXPENSES 17,787. FUNDRAISING EXPENSES 10,569. TOTAL EXPENSES 103,641. PAYROLL FEES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 18,893. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 18,893. WEB DESIGN: PROGRAM SERVICE EXPENSES 8,214. MANAGEMENT AND GENERAL EXPENSES 2,453. FUNDRAISING EXPENSES 1,015. TOTAL EXPENSES 11,682. TEMPORARY HELP: PROGRAM SERVICE EXPENSES 7,626. MANAGEMENT AND GENERAL EXPENSES 1,339. FUNDRAISING EXPENSES 461. TOTAL EXPENSES 9,426. FORM 990, PART XI, LINE 9: GRANT REFUNDS 4,974.